You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 9, September 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Surgical Technique
 This Article
 •Abstract
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Glaucoma
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Newer Technique for Glaucoma Tube Trimming

Sanjay Asrani, MD; Leon Herndon, MD; R. Rand Allingham, MD

Arch Ophthalmol. 2003;121:1324-1326.

ABSTRACT

Long silicone glaucoma tubes within the anterior chamber are frequently detrimental to the corneal endothelium and other anterior chamber structures. Tube shortening often involves extensive and potentially complicated surgery that requires tube removal and reinsertion. A new technique is described for trimming the silicone tube in situ. Besides permitting tube length modification within the anterior chamber, it also decreases operative time substantially. A representative case is described.



INTRODUCTION
 Jump to Section
 •Top
 •Introduction
 •Procedure
 •Representative case
 •Author information
 •References

Aqueous tube shunts have been used for the treatment of complicated glaucoma for decades.1 Shunts are increasingly being used in children because of the low success rate of filtering procedures and to avoid complications.2-3 Despite their success, aqueous tube shunts may cause substantial complications, many of which occur in the anterior segment. In a substantial number of cases, the implant tube position has to be modified postoperatively.1, 4-5 A long tube in the anterior chamber can be detrimental to the long-term health of the corneal endothelium, especially in eyes with shallow anterior chambers such as those with hypotony or corneal transplants. The rate of endothelial failure is 17% to 35%2, 6-7 in cases in which intermittent tube-corneal contact occurs. This situation results in a gradual onset of corneal edema that initially is localized and then becomes generalized. Long tubes can cause chronic iritis or cataract formation when there is contact with the iris or the lens. Furthermore, cataract surgery is technically more difficult in the presence of a long tube in the anterior chamber.

In some cases, tube length and placement are acceptable at the time of surgery, but the tube may lengthen or become redirected postoperatively. This change can be secondary to a variety of factors, such as movement of the implant, changes in intraocular pressure, or movement of the tube itself. The final tube position may not be desirable if it is in contact with certain intraocular structures. In these cases, the tube has to be shortened.

Trimming the tube has so far involved major surgery. This surgery typically involves dissection through a scarred conjunctiva, dissection underneath the scleral patch graft, removal of the tube from the anterior chamber, trimming of the tube, and subsequent tube reinsertion and suturing. This process can be lengthy and may be fraught with complications such as tube transection during scleral patch dissection, difficulty with tube reinsertion, and nonhealing of the wound with subsequent tube exposure and risk of epithelial downgrowth and postoperative hypotony.


PROCEDURE
 Jump to Section
 •Top
 •Introduction
 •Procedure
 •Representative case
 •Author information
 •References

To prevent complications that may occur with traditional methods of tube shortening, we describe a newer technique. After application of topical anesthesia with the usual sterile conditions in the operating room, 2 paracentesis sites are created by using a Beaver supersharp blade (Becton, Dickinson and Co, Franklin Lakes, NJ). One is positioned directly across from the tube entry site into the anterior chamber 180° away and the other 90° away from the tube entry site (Figure 1). The anterior chamber is filled with a viscoelastic agent, and a 30-gauge needle on a 1-mL syringe is advanced from the paracentesis site 180° away (Figure 2). The needle is advanced into the tube lumen to stent the tube. This procedure is followed by the insertion of a manual right-angled membrane peeling and cutting scissors (Alcon Grieshaber AG, Schaffhausen, Switzerland) from the other paracentesis site. The scissors is positioned over the tube beyond the stenting needle, and the tube is transected (Figure 3). The scissors is then withdrawn from the anterior chamber, and an end-gripping vitreoretinal forceps (Alcon Grieshaber AG) or an Utrata forceps is inserted through the same paracentesis site.



View larger version (91K):
[in this window]
[in a new window]
Figure 1. A right-angled membrane peeling and cutting scissors demonstrates its side-cutting technique in the presence of a long tube that touches the lens.




View larger version (92K):
[in this window]
[in a new window]
Figure 2. A 30-gauge needle is inserted through the inferior paracentesis site to stent the tube after injection of a viscoelastic agent.




View larger version (111K):
[in this window]
[in a new window]
Figure 3. The right-angled membrane peeling and cutting scissors is inserted through the paracentesis site 90° from the tube entry site and transects the tube.


During this time, the tube's distal end remains in the anterior chamber on the tip of the 30-gauge needle. The forceps then grasps the distal tube fragment at the cut end, and the fragment is removed from the anterior chamber by withdrawing the forceps (Figure 4). The pliable silicone tube fragment usually offers no resistance to removal through the paracentesis site. The needle is withdrawn simultaneously. The viscoelastic agent can be removed from the anterior chamber with the help of manual irrigation and aspiration with balanced salt solution with a syringe and cannula. This procedure is followed by stromal hydration of the paracentesis sites to ensure a watertight closure.



View larger version (107K):
[in this window]
[in a new window]
Figure 4. The end-gripping forceps is used to grasp the tube fragment and withdraw it from the anterior chamber.


In the presence of a malpositioned tube in which cannulation with a needle is difficult, a slight modification of this procedure is used. Two paracentesis sites are created on either side of the tube, typically at the 3- and 9-o'clock positions. An end-gripping forceps is introduced through one paracentesis site to hold the tube, and a Sutherland scissors (Alcon Grieshaber AG) through the other site to transect the tube, which is then withdrawn from the anterior chamber with the forceps.

Possible complications include injury to intraocular structures during manipulation with various instruments. A small amount of viscoelastic agent, if left behind in the anterior chamber, does not result in a postoperative pressure spike because of the presence of a patent tube.


REPRESENTATIVE CASE
 Jump to Section
 •Top
 •Introduction
 •Procedure
 •Representative case
 •Author information
 •References

A 46-year-old man who underwent glaucoma tube surgery for uncontrolled intraocular pressure had an acceptable tube placement intraoperatively. Postoperatively, the tube was touching the center of the lens. Within a few days, the patient developed a cataract necessitating removal. Because the long tube was in the visual axis in the anterior chamber, which would make cataract surgery difficult to perform, the tube was trimmed prior to the start of the cataract surgery. The tube was trimmed short in the manner described earlier, and cataract surgery proceeded in the usual manner. There were no complications after the procedure; intraocular pressure control was maintained.


AUTHOR INFORMATION
 Jump to Section
 •Top
 •Introduction
 •Procedure
 •Representative case
 •Author information
 •References

Corresponding author: Sanjay Asrani, MD, Duke University Eye Center, Box 3802, Durham, NC 27710 (e-mail: asran002{at}mc.duke.edu).

Submitted for publication September 24, 2002; final revision received April 3, 2003; accepted May 14, 2003.

From the Duke University Eye Center, Durham, NC. The authors have no relevant financial interest in this article.


REFERENCES
 Jump to Section
 •Top
 •Introduction
 •Procedure
 •Representative case
 •Author information
 •References

1. Sherwood MB, Smith MF, Driebe WT Jr, et al. Drainage tube implants in the treatment of glaucoma following penetrating keratoplasty. Ophthalmic Surg. 1993;24:185-189. WEB OF SCIENCE | PUBMED
2. Hill RA, Heuer DK, Baerveldt G, et al. Molteno implantation for glaucoma in young patients. Ophthalmology. 1991;98:1042-1046. WEB OF SCIENCE | PUBMED
3. Netland PA, Walton DS. Glaucoma drainage implants in pediatric patients. Ophthalmic Surg. 1993;24:723-729. WEB OF SCIENCE | PUBMED
4. Tsai JC, Grajewski AL, Parrish RK II. Surgical revision of glaucoma shunt implants. Ophthalmic Surg Lasers. 1999;30:41-46. WEB OF SCIENCE | PUBMED
5. Billson F, Thomas R, Grigg J. Resiting Molteno implant tubes. Ophthalmic Surg Lasers. 1996;27:801-803. WEB OF SCIENCE | PUBMED
6. Gandham SB, Costa VP, Katz LJ, et al. Aqueous tube-shunt implantation and pars plana vitrectomy in eyes with refractory glaucoma. Am J Ophthalmol. 1993;116:189-195. WEB OF SCIENCE | PUBMED
7. Siegner SW, Netland PA, Urban RC Jr, et al. Clinical experience with the Baerveldt glaucoma drainage implant. Ophthalmology. 1995;102:1298-1307. WEB OF SCIENCE | PUBMED


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.